Imatero 400 mg Tablet

Imatero 400 mg Tablet contains imatinib mesylate 400 mg and is an oral targeted anticancer medicine. It is used for certain blood cancers, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, as well as gastrointestinal stromal tumors. The tablet is a prescription medicine and should be used under the supervision of an oncologist.

BUY NOW

Imatinib belongs to the tyrosine kinase inhibitor class and works by blocking abnormal proteins involved in the growth and survival of certain cancer cells. It may also be used for selected conditions such as aggressive systemic mastocytosis and dermatofibrosarcoma protuberans according to the prescribed indication. Imatero should generally be taken with food and swallowed whole with water to reduce gastrointestinal irritation. Regular blood tests, liver-function assessment, and clinical monitoring may be required during treatment.

Technical Specification

Specification Details
Active Ingredient Imatinib Mesylate
Strength 400 mg
Dosage Form Tablet
Pack Size 10 tablets
Route of Administration Oral
Manufacturer/Marketer Hetero Healthcare Limited

Product Also Known As

Imatero 400mg Tablet, Imatero 400 mg Tablet, Imatero 400 Tablet, Imatinib Mesylate 400mg Tablet, Imatinib Mesylate 400 mg Tablet, Imatinib 400mg Tablet, Imatinib Oral Tablet